Skip to main content
Top
Published in: Breast Cancer Research 1/2006

01-02-2006 | Letter

Is there a positive association between mammographic density and bone mineral density?

Authors: Gillian S Dite, John D Wark, Graham G Giles, Dallas R English, Margaret RE McCredie, John L Hopper

Published in: Breast Cancer Research | Issue 1/2006

Login to get access

Excerpt

In a recent issue of this journal, Crandall and colleagues [1] reported a positive association between percent mammo-graphic density and bone mineral density at the hip and lumbar spine in postmenopausal women. These associations were only observed after excluding women who were "recent" users of hormone replacement therapy and even then were of marginal, and not independent, significance (p = 0.04 and p = 0.08, respectively). The previously reported null findings from the larger studies by Kerlikowske and colleagues [2] and Buist and colleagues [3] were discounted by Crandall and colleagues [1] for not having stratified by hormone replacement therapy use. In a recent publication from our twin study we found no overlap between the genetic determinants of variation in percent mammographic density and bone mineral density [4]. …
Literature
1.
go back to reference Crandall C, Palla S, Reboussin BA, Ursin G, Greendale GA: Positive association between mammographic breast density and bone mineral density in the Postmenopausal Estrogen/Progestin Interventions Study. Breast Cancer Res. 2005, 7: R922-R928. 10.1186/bcr1327.CrossRefPubMedPubMedCentral Crandall C, Palla S, Reboussin BA, Ursin G, Greendale GA: Positive association between mammographic breast density and bone mineral density in the Postmenopausal Estrogen/Progestin Interventions Study. Breast Cancer Res. 2005, 7: R922-R928. 10.1186/bcr1327.CrossRefPubMedPubMedCentral
2.
go back to reference Kerlikowske K, Shepherd J, Ceasman J, Tice JA, Ziv E, Cummings SR: Are breast density and bone mineral density independent risk factors for breast cancer?. J Natl Cancer Inst. 2005, 97: 368-374.CrossRefPubMed Kerlikowske K, Shepherd J, Ceasman J, Tice JA, Ziv E, Cummings SR: Are breast density and bone mineral density independent risk factors for breast cancer?. J Natl Cancer Inst. 2005, 97: 368-374.CrossRefPubMed
3.
go back to reference Buist DSM, Anderson ML, Taplin SH, LaCroix AZ: The relationship between breast density and bone mineral density in postmenopausal women. Cancer. 2004, 101: 1968-1976. 10.1002/cncr.20565.CrossRefPubMed Buist DSM, Anderson ML, Taplin SH, LaCroix AZ: The relationship between breast density and bone mineral density in postmenopausal women. Cancer. 2004, 101: 1968-1976. 10.1002/cncr.20565.CrossRefPubMed
4.
go back to reference Dite GS, Wark JD, Giles GG, English DR, McCredie MRE, Hopper JL: Is there overlap between the genetic determinants of mammographic density and bone mineral density?. Cancer Epidemiol Biomarkers Prev. 2005, 14: 2266-2268. 10.1158/1055-9965.EPI-05-0279.CrossRefPubMed Dite GS, Wark JD, Giles GG, English DR, McCredie MRE, Hopper JL: Is there overlap between the genetic determinants of mammographic density and bone mineral density?. Cancer Epidemiol Biomarkers Prev. 2005, 14: 2266-2268. 10.1158/1055-9965.EPI-05-0279.CrossRefPubMed
5.
go back to reference Hopper JL: Review of: Are breast density and bone mineral density independent risk factors for breast cancer?. Breast Cancer Online. 2005, 8: e58-10.1017/S1470903105004761.CrossRef Hopper JL: Review of: Are breast density and bone mineral density independent risk factors for breast cancer?. Breast Cancer Online. 2005, 8: e58-10.1017/S1470903105004761.CrossRef
Metadata
Title
Is there a positive association between mammographic density and bone mineral density?
Authors
Gillian S Dite
John D Wark
Graham G Giles
Dallas R English
Margaret RE McCredie
John L Hopper
Publication date
01-02-2006
Publisher
BioMed Central
Published in
Breast Cancer Research / Issue 1/2006
Electronic ISSN: 1465-542X
DOI
https://doi.org/10.1186/bcr1383

Other articles of this Issue 1/2006

Breast Cancer Research 1/2006 Go to the issue
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine